109 related articles for article (PubMed ID: 6094810)
1. Synthesis and biological activity of new peptide segments of gastrin exhibiting gastrin antagonist property.
Martinez J; Magous R; Lignon MF; Laur J; Castro B; Bali JP
J Med Chem; 1984 Dec; 27(12):1597-601. PubMed ID: 6094810
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: the importance of the peptide backbone.
Martinez J; Bali JP; Rodriguez M; Castro B; Magous R; Laur J; Lignon MF
J Med Chem; 1985 Dec; 28(12):1874-9. PubMed ID: 2999406
[TBL] [Abstract][Full Text] [Related]
3. Abilities of some tryptophan and phenylalanine derivatives to inhibit gastric acid secretion.
Magous R; Martinez J; Lignon MF; Nisato D; Castro B; Bali JP
Biochim Biophys Acta; 1985 May; 845(2):158-62. PubMed ID: 2986716
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of C-terminal tri- and tetrapeptide fragments that inhibit gastrin activity.
Martinez J; Bali JP; Magous R; Laur J; Lignon MF; Briet C; Nisato D; Castro B
J Med Chem; 1985 Mar; 28(3):273-8. PubMed ID: 3973899
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of gastrin antagonists, analogues of the C-terminal tetrapeptide of gastrin, by introduction of a beta-homo residue.
Rodriguez M; Fulcrand P; Laur J; Aumelas A; Bali JP; Martinez J
J Med Chem; 1989 Mar; 32(3):522-8. PubMed ID: 2918498
[TBL] [Abstract][Full Text] [Related]
6. A new class of potent gastrin antagonists.
Martinez J; Bali JP
Regul Pept; 1984 Nov; 9(4):259-62. PubMed ID: 6097950
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Z-CCK-27-32-NH2, Z-Tyr(SO-3)-Met-Gly-Trp-Met-Asp-NH2, a cholecystokinin receptor antagonist and an inhibitor of gastrin-induced acid secretion.
Briet C; Aumelas A; Martinez J
Int J Pept Protein Res; 1985 Sep; 26(3):294-8. PubMed ID: 2997059
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of partially modified retro-inverso pseudopeptide derivatives of the C-terminal tetrapeptide of gastrin.
Rodriguez M; Dubreuil P; Bali JP; Martinez J
J Med Chem; 1987 May; 30(5):758-63. PubMed ID: 3572963
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion.
Rodriguez M; Bali JP; Magous R; Castro B; Martinez J
Int J Pept Protein Res; 1986 Mar; 27(3):293-9. PubMed ID: 3011690
[TBL] [Abstract][Full Text] [Related]
10. Biological effects of human gastrin I and II chemically modified at the C-terminal tetrapeptide amide.
Galleyrand JC; Fulcrand P; Bali JP; Rodriguez M; Magous R; Laur J; Martinez J
Peptides; 1992; 13(3):519-25. PubMed ID: 1523164
[TBL] [Abstract][Full Text] [Related]
11. Novel C-terminal gastrin antagonists. Synthesis and biological activity.
Yasui A; Douglas AJ; Walker B; Magee DF; Murphy RF
Int J Pept Protein Res; 1990 Apr; 35(4):301-5. PubMed ID: 2345051
[TBL] [Abstract][Full Text] [Related]
12. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
13. Effect of Nin-formylation of the tryptophan residue on gastrin (HG-13) binding and on gastric acid secretion.
Magous R; Bali JP; Moroder L; Previero A
Eur J Pharmacol; 1982 Jan; 77(1):11-6. PubMed ID: 6277651
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.
Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V
Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of carboxy-terminal gastrin analogs.
Sandvik AK; Dockray GJ
Eur J Pharmacol; 1999 Jan; 364(2-3):199-203. PubMed ID: 9932724
[TBL] [Abstract][Full Text] [Related]
16. Dispensability of both the amide of phenylalanine and the carboxyl group of aspartic acid for the stimulation of gastric acid secretion by gastrin peptides in dogs.
Lin TM; Spray GF; Southard GL
Gastroenterology; 1977 Mar; 72(3):566-8. PubMed ID: 832807
[TBL] [Abstract][Full Text] [Related]
17. COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists.
Jensen RT; Jones SW; Gardner JD
Biochim Biophys Acta; 1983 May; 757(2):250-8. PubMed ID: 6189522
[TBL] [Abstract][Full Text] [Related]
18. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
19. The role of the Asp-32 residue of cholecystokinin in gastric acid secretion and gastrin receptor recognition.
Magous R; Martinez J; Lignon MF; Bali JP
Regul Pept; 1983 Mar; 5(4):327-32. PubMed ID: 6304819
[TBL] [Abstract][Full Text] [Related]
20. Bioactivity studies on new gastrin analogues.
Haugen SE; Douglas AJ; Rønning B; Walker B; Sandvik AK; Murphy RF; Elmore DT; Waldum HL
Scand J Gastroenterol; 1989 Jun; 24(5):577-80. PubMed ID: 2762757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
